{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"glycine-n-methyltransferase-deficiency","columns":[{"gene":"","key":"population-511e5594ef952186e09f","label":"GLYCINE N-METHYLTRANSFERASE DEFICIENCY","mondoId":"MONDO:0011698","onsetQualifier":null,"originColumnKey":"MONDO:0011698/OMIM:606664","originalViews":[{"key":"MONDO:0011698/OMIM:606664","label":"GLYCINE N-METHYLTRANSFERASE DEFICIENCY","scopeLabel":"OMIM:606664","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["0f481cb28073a7450c8e5d960be6ebbc990f2ee987cc227db5f3d65adce94176","29f7a27df0ecd528dd7c93d8e2f591ad33509d8cf9e99cb277d2dff07aa4d03a","4745908d2844a371dd281c682aaa7a7e2ea82cb256d87e4bcf67690ed1de33d2"],"recordQualifiers":{},"scopeLabel":"OMIM:606664","sourceIds":["OMIM:606664"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-511e5594ef952186e09f"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002910","HP:0002240","HP:0003235"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":3,"sourceGroups":{"omim":3}},"features":[{"hpoId":"HP:0002910","label":"Elevated circulating hepatic transaminase concentration","primary":true},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":true},{"hpoId":"HP:0003235","label":"Hypermethioninemia","primary":true}],"ledeHtml":"Hypermethioninemia due to glycine N-methyltransferase deficiency (GNMT deficiency) is a very rare condition characterized by persistent and isolated excess levels of methionine in the blood (hypermethioninemia). The only clinical abnormalities are mild increase of the liver size (hepatomegaly) and chronic elevation of the transaminase levels in the blood without liver disease. Methionine may also be increased in urine. However, because elevated levels of methionine in the blood itself is a risk factor for development of neurological signs and symptoms, people with hypermethioninemia due to glycine N-methyltransferase deficiency can have neurological problems when methionine levels are greater than 800 μmol/L. GNMT deficiency is caused by genetic changes in the GNMT gene. Inheritance is autosomal recessive.","mondoId":"MONDO:0011698","node":{"canonicalSlug":"glycine-n-methyltransferase-deficiency","comparisons":[{"documentSha256":"4ea989a9a4bd2d8ddcaf01111dab97345e3d12344c41bc421017dbaeb953ac37","key":"legacy-hypermethioninemia","kind":"legacy","label":"disorder of methionine catabolism","memberIds":["MONDO:0000351","MONDO:0011698","MONDO:0013404"],"mondoId":"MONDO:0000351","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hypermethioninemia.4ea989a9a4bd2d8ddcaf01111dab97345e3d12344c41bc421017dbaeb953ac37.json"},{"documentSha256":"78af0af9411896cce741daaacd50d1dedad82453dcecc7475bd003ebeab0a276","key":"expanded-hypermethioninemia","kind":"expanded","label":"disorder of methionine catabolism","memberIds":["MONDO:0000351","MONDO:0011698","MONDO:0013404","MONDO:0100255"],"mondoId":"MONDO:0000351","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-78af0af9411896cce741.78af0af9411896cce741daaacd50d1dedad82453dcecc7475bd003ebeab0a276.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Glycine N-methyltransferase deficiency","originalSourceId":"ORPHA:289891","paragraphs":["Hypermethioninemia due to glycine N-methyltransferase deficiency (GNMT deficiency) is a very rare condition characterized by persistent and isolated excess levels of methionine in the blood (hypermethioninemia). The only clinical abnormalities are mild increase of the liver size (hepatomegaly) and chronic elevation of the transaminase levels in the blood without liver disease. Methionine may also be increased in urine. However, because elevated levels of methionine in the blood itself is a risk factor for development of neurological signs and symptoms, people with hypermethioninemia due to glycine N-methyltransferase deficiency can have neurological problems when methionine levels are greater than 800 μmol/L. GNMT deficiency is caused by genetic changes in the GNMT gene. Inheritance is autosomal recessive."],"rawAttribution":"MONDO:0011698","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:41:19Z","upstream":"GARD:0010764","url":"https://rarediseases.info.nih.gov/diseases/10764"},"ownColumnKeys":["population-511e5594ef952186e09f"],"publication":"published","relationships":[{"kind":"parent","label":"disorder of methionine catabolism","mondoId":"MONDO:0000351","slug":"hypermethioninemia"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"0f481cb28073a7450c8e5d960be6ebbc990f2ee987cc227db5f3d65adce94176","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:606664","disease_name":"GLYCINE N-METHYLTRANSFERASE DEFICIENCY","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003235","is_excluded":false,"label":"Hypermethioninemia","onset_id":null,"reference":"OMIM:606664","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"29f7a27df0ecd528dd7c93d8e2f591ad33509d8cf9e99cb277d2dff07aa4d03a","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:606664","disease_name":"GLYCINE N-METHYLTRANSFERASE DEFICIENCY","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"OMIM:606664","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"4745908d2844a371dd281c682aaa7a7e2ea82cb256d87e4bcf67690ed1de33d2","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:606664","disease_name":"GLYCINE N-METHYLTRANSFERASE DEFICIENCY","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002910","is_excluded":false,"label":"Elevated circulating hepatic transaminase concentration","onset_id":null,"reference":"OMIM:606664","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/10764\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011698\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0010764</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Hypermethioninemia due to glycine N-methyltransferase deficiency (GNMT deficiency) is a very rare condition characterized by persistent and isolated excess levels of methionine in the blood (hypermethioninemia). The only clinical abnormalities are mild increase of the liver size (hepatomegaly) and chronic elevation of the transaminase levels in the blood without liver disease. Methionine may also be increased in urine. However, because elevated levels of methionine in the blood itself is a risk factor for development of neurological signs and symptoms, people with hypermethioninemia due to glycine N-methyltransferase deficiency can have neurological problems when methionine levels are greater than 800 μmol/L. GNMT deficiency is caused by genetic changes in the GNMT gene. Inheritance is autosomal recessive.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/10764\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"glycine-n-methyltransferase-deficiency","sourceDocuments":[{"name":"GARD: Glycine N-methyltransferase deficiency","reviewed":null,"source_release":"2026-10-25T03:41:19Z","url":"https://rarediseases.info.nih.gov/diseases/10764"},{"name":"MONDO: glycine N-methyltransferase deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0011698"}],"sourceNote":"","synonyms":["Glycine N-methyltransferase deficiency","glycine N-methyltransferase deficiency","GNMT deficiency","hypermethioninemia due to glycine N-methyltransferase deficiency","hypermethioninemia due to GNMT deficiency"],"takeawayHtml":"","title":"glycine N-methyltransferase deficiency"},"schemaVersion":1}
